Evaluate Efficacy, Immunological Response of Intratumoral/Intralesional Oncolytic Virus (OBP-301) in Metastatic Melanoma
Clinical trial NCT03190824 · UNKNOWN
Trial details
- NCT number
- NCT03190824
- Sponsor
- Syneos Health
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-22
- Primary completion
- 2021-06-24
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.